PKO Investment Management Joint-Stock’s Akebia Therapeutics AKBA Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-622,796	Closed	-$1.79M	–	106
2021 Q3	$1.79M	Sell	622,796 -4,536	-0.7%	-$13K	0.22%	79
2021 Q2	$2.38M	Hold	627,332	–	–	0.3%	59
2021 Q1	$2.12M	Hold	627,332	–	–	0.34%	49
2020 Q4	$1.76M	Hold	627,332	–	–	0.3%	53
2020 Q3	$1.57M	Hold	627,332	–	–	0.31%	56
2020 Q2	$8.52M	Buy	627,332 +80,030	+15%	+$828K	1.93%	22
2020 Q1	$4.15M	Hold	547,302	–	–	1.41%	26
2019 Q4	$3.46M	Sell	547,302 -1,074	-0.2%	-$5.11K	0.86%	31
2019 Q3	$2.15M	Hold	548,376	–	–	0.55%	43
2019 Q2	$2.65M	Hold	548,376	–	–	0.67%	38
2019 Q1	$4.49M	Hold	548,376	–	–	1.18%	24
2018 Q4	$3.03M	Buy	+548,376	New	+$4.29M	0.86%	34

Other funds holding AKBA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PKO Investment Management Joint-Stock's AKBA Position: Q4 2021 in Review

PKO Investment Management Joint-Stock sold out of Akebia Therapeutics (AKBA) in Q4 2021, closing a stake of 622,796 shares — an estimated $1.79M sold.

PKO Investment Management Joint-Stock first reported a position in AKBA in Q4 2018 and held it in 12 quarters. The position peaked at $8.52M in Q2 2020. 133 funds tracked by Wall St. Rank hold AKBA as of Q4 2021.

PKO Investment Management Joint-Stock reported no remaining Akebia Therapeutics position as of Q4 2021 after selling out during the quarter.
PKO Investment Management Joint-Stock sold 622,796 Akebia Therapeutics shares in Q4 2021, an estimated $1.79M.
PKO Investment Management Joint-Stock first reported a position in Akebia Therapeutics in Q4 2018 and held it in 12 quarters.
PKO Investment Management Joint-Stock's Akebia Therapeutics position peaked at $8.52M in Q2 2020.
133 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2021.

Based on PKO Investment Management Joint-Stock's 13F filing for Q4 2021, filed 13 Mar 2025.